Search

Search Constraints

You searched for: Author/Creator Asnafi, V.

Search Results

1. Clinical aspects and outcome of lymphoblastic leukemia/lymphoma with cutaneous involvement. (2019)

2. KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET. (12th June 2019)

3. MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA. (12th June 2019)

4. NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T‐CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY. (June 2017)

5. Prognostic value of PET/CT and CT in T‐cell lymphoblastic lymphoma/leukaemia patients: A retrospective cohort study of 145 patients. (8th March 2023)